The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1033834326 10338343 26 F 201203 20160928 20140724 20160930 EXP CA-ROCHE-1098542 ROCHE 44.21 YR F Y 88.00000 KG 20160930 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1033834326 10338343 1 PS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 660 MG SOLUTION FOR INFUSION
1033834326 10338343 2 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 600 MG SOLUTION FOR INFUSION
1033834326 10338343 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 600 MG SOLUTION FOR INFUSION
1033834326 10338343 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 560 MG SOLUTION FOR INFUSION
1033834326 10338343 5 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 560 MG SOLUTION FOR INFUSION
1033834326 10338343 6 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 480 MG SOLUTION FOR INFUSION
1033834326 10338343 7 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 SOLUTION FOR INFUSION
1033834326 10338343 8 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 440 MG SOLUTION FOR INFUSION
1033834326 10338343 9 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 400 MG SOLUTION FOR INFUSION
1033834326 10338343 10 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 400 MG SOLUTION FOR INFUSION
1033834326 10338343 11 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 480 MG SOLUTION FOR INFUSION
1033834326 10338343 12 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) B20373,B20243,B2032,B2024,B2044,B20 125276 400 MG SOLUTION FOR INFUSION
1033834326 10338343 13 SS SULFASALAZINE. SULFASALAZINE 1 Unknown D 0
1033834326 10338343 14 C TYLENOL WITH CODEINE ACETAMINOPHENCODEINE PHOSPHATE 1 Y 0
1033834326 10338343 15 C ADVIL IBUPROFEN 1 0
1033834326 10338343 16 C PREDNISONE. PREDNISONE 1 0
1033834326 10338343 17 C SYNTHROID LEVOTHYROXINE SODIUM 1 0
1033834326 10338343 18 C CYCLOSPORINE. CYCLOSPORINE 1 0
1033834326 10338343 19 C LEFLUNOMIDE. LEFLUNOMIDE 1 0
1033834326 10338343 20 C CYCLOSPORINE. CYCLOSPORINE 1 0
1033834326 10338343 21 C AMLODIPINE AMLODIPINE BESYLATE 1 Unknown 0 5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1033834326 10338343 1 Rheumatoid arthritis
1033834326 10338343 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
1033834326 10338343 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1033834326 10338343 Abdominal pain
1033834326 10338343 Arthralgia
1033834326 10338343 Blood pressure diastolic increased
1033834326 10338343 Blood pressure increased
1033834326 10338343 Breath sounds abnormal
1033834326 10338343 Candida infection
1033834326 10338343 Dysuria
1033834326 10338343 Headache
1033834326 10338343 Hepatic enzyme increased
1033834326 10338343 Hypertension
1033834326 10338343 Incorrect dose administered
1033834326 10338343 Infection
1033834326 10338343 Influenza
1033834326 10338343 Infusion related reaction
1033834326 10338343 Localised infection
1033834326 10338343 Muscle strain
1033834326 10338343 Nasopharyngitis
1033834326 10338343 Pain
1033834326 10338343 Productive cough
1033834326 10338343 Rash
1033834326 10338343 Teeth brittle
1033834326 10338343 Thyroid function test abnormal
1033834326 10338343 Toothache
1033834326 10338343 Upper respiratory tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1033834326 10338343 1 20111219 0
1033834326 10338343 2 20120416 0
1033834326 10338343 3 20120710 0
1033834326 10338343 4 20120727 0
1033834326 10338343 5 20121002 0
1033834326 10338343 6 20121030 0
1033834326 10338343 7 20140428 0
1033834326 10338343 8 20140707 0
1033834326 10338343 9 20150202 0
1033834326 10338343 10 20150921 0
1033834326 10338343 11 20151015 0
1033834326 10338343 12 20160528 0